Originally published in our sister publication, Pain Medicine News.
Two prospective multicenter studies of a recently FDA-approved recharge-free neurostimulation implantable system for treating chronic pain showed significantly positive results for reduced Pain Catastrophizing Scale scores.
“For the longest time in pain medicine, we have focused on pain scores,” said Steven Falowski, MD, the director of functional neurosurgery at Neurosurgical Associates of Lancaster, in Pennsylvania.